To view this email as a web page, click here.
 
New postpartum drug comes at a high price
Postpartum drug is a game changer, but can women afford it?
Read more
 
FDA announces 3 big drug recalls
Several companies are recalling products due to contamination from substances such as carcinogens and glass—here’s what you should know.
Read more
 
Top barriers to biosimilar approval and adoption in the U.S.
From our sister brand, Managed Healthcare Executive: The biosimilar market is flourishing in Europe—why aren’t we seeing similar gains in the U.S.?
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.